Drugs / adrenocorticotropic hormone
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT02155803 | Feb → Jun 2015 | hypercalcemic sarcoidosis | Albany Medical College | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | adrenocorticotropic hormone | “ACTHAR GEL (adrenocorticotropic hormone) 80 units subcutaneously twice weekly for 12 weeks” NCT02155803 ↗ |
| Known as | ACTHAR GEL | “ACTHAR GEL (adrenocorticotropic hormone) 80 units subcutaneously twice weekly for 12 weeks” NCT02155803 ↗ |
| Action | Activate | “it may also activate melanocortin receptors” NCT02155803 ↗ |
| Route | Subcutaneous | “80 units subcutaneously twice weekly” NCT02155803 ↗ |